Sue Heatley

Sue Heatley

Adelaide Medical School

Faculty of Health and Medical Sciences

Eligible to supervise Masters and PhD - email supervisor to discuss availability.


Dr Sue Heatley
Genomics Research Team Leader at South Australian Health & Medical Research Institute Australia

Previous:
Centre for Cancer Biology,
Australian Red Cross Blood Service,
St Jude Children's Research Hospital

Education:
University of Melbourne

Experience:

Genomics Research Team Leader
South Australian Health & Medical Research Institute
July 2013 – Present (3 years 5 months)|Adelaide

Postdoctoral Scientist
Centre for Cancer Biology
August 2011 – June 2013 (1 year 11 months)|Adelaide

Medical Education Project Officer
Australian Red Cross Blood Service
July 2009 – August 2011 (2 years 2 months)|Adelaide

Visiting Postdoctoral Fellow
St Jude Children's Research Hospital
June 2010 – February 2011 (9 months)|Memphis, TN, USA

Medical Scientist, Research & Development
Australian Red Cross Blood Service
January 1998 – June 2009 (11 years 6 months)|Adelaide

Medical Scientist/Technical Officer/Nurse attendant
Australian Red Cross Blood Service
October 1984 – December 1997 (13 years 3 months)|Adelaide

Dr Sue Heatley gained her PhD in Transplant Immunology from the University of Melbourne in 2011. She also has a Masters in Education (Educational Leadership). In 2010 she was awarded a New Investigator Scholarship by the Haematology Society of Australia & New Zealand (HSANZ) to undertake a visiting fellow position in the laboratory of Prof Charles Mullighan at the St Jude’s Children’s Research Hospital, Memphis, TN, USA. In 2013, Sue accepted her current position at SAHMRI in the Leukaemia Research group of Prof Deb White and Prof Tim Hughes in the Cancer Theme. She is a member of several professional societies including HSANZ and the Australian & New Zealand Children’s Haematology and Oncology Group.

Sue has extensive laboratory experience having worked at the Australian Red Cross Blood Service for over 25 years including over 12 years in the Research Department and 2 years in Medical Education. She has presented her research at both national and international meetings, being awarded the prestigious Albert Baikie Memorial Medal in 2015 for best presentation by a new investigator. Sue has authored over 30 publications with over 3000 career citations and is the current Kids Cancer Project Postdoctoral Fellow. Her current research interests are focussed on the genomic landscape of ALL and improving patient outcome through personalised medicine.

Grant Funding:

July 1 2016- June 30 2017 The Kids Cancer Project $170,932

Elucidating drug sensitivity and clonal evolution of Ph-like ALL in adolescents.

Fellowship: Susan Heatley

2015 Channel 7 Children’s Research Foundation $75,000

Developing a robust screening tool to identify children with high risk “Ph-like” Acute Lymphoblastic Leukaemia (ALL) that will lead to improved outcomes through the use of targeted therapies.

CIA Susan Heatley, CIB Deborah White, CIC Charles Mullighan

    Expand
  • Current Higher Degree by Research Supervision (University of Adelaide)

    Date Role Research Topic Program Degree Type Student Load Student Name
    2018 Co-Supervisor Cytokine receptor like factor 2 rearrangements (CRLF2r) are high risk in Down Syndrome Acute Lymphoblastic Leukaemia (DS ALL). This project focuses on finding a combination therapy using small molecule inhibitors to decrease the serious toxicities DS patients experience from chemotherapy. Doctor of Philosophy Doctorate Full Time Miss Elyse Chenae Page
    2017 Co-Supervisor Characterising novel genomlc lesions to develop a new comblnatlonal therapeutic strategy, in high-risk acute lymphoblastic leukaemia (ALL) categorized by JAK fusions IL-7R and polycomb repressor complex 2 mutations Doctor of Philosophy Doctorate Full Time Miss Paniz Tavakoli Shirazi
  • Past Higher Degree by Research Supervision (University of Adelaide)

    Date Role Research Topic Program Degree Type Student Load Student Name
    2015 - 2018 Co-Supervisor In vitro Modelling of High-risk ALL Fusions Uncovers Genomic Alterations and Non-canonical Signalling Pathways as a Mode of TKI-Resistance - Implications for Targeted Therapy Doctor of Philosophy Doctorate Full Time Miss Kartini Asari

Connect With Me
External Profiles